These results indicated the protective effects of baicalin in AD progression were related to the inhibition of microglia-induced neuroinflammation by suppressing the activation of NLRP3 inflammasomes and the TLR4/NF-κB signaling pathway [51]. Here, TLR4 is linked to Alzheimer disease.